Company intelligence / Profile preview

Kai MedTech

Lake Forest, California, United Stateskaimedtech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Kai MedTech has commercialized nine NMPA Class III products in China and one product with US FDA 510(k) clearance as of March 2023, focusing on innovative neurovascular and endovascular interventional devices[4]. The company is building a global innovation platform for cerebrovascular disease equipment.

Therapeutic areas: CardiovascularNeurology
Modalities: Device (specifically, interventional and implantable medical devices)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Kai MedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kai MedTech.

Explore the full profile